Market

The Neonatal Fc receptor has emerged as a high-value target in immunology because it plays a critical role in recycling the antibodies that sustain autoimmune activity. This shift toward complex, target-specific medicine is forcing the global pharmaceutical infrastructure to evolve beyond simple

The global medical supply chain relies heavily on Indian manufacturing, making any shift in domestic pharmaceutical regulations a matter of international concern for healthcare providers and patients alike. The Ministry of Health recently proposed rigorous amendments to the Drugs Rules, signaling a

The Carlsbad facility brings end-to-end viral vector solutions and aseptic fill-finish capabilities to Lonza, catering specifically to the burgeoning cell and gene therapy market. This strategic acquisition of five specialized contract development and manufacturing organization (CDMO) sites from

New federal mandates target the opaque financial arrangements between Pharmacy Benefit Managers and health plans to ensure service compensation remains reasonable under federal law. For decades, the "black box" of prescription drug pricing has frustrated employers who struggle to reconcile rising

Eight years of data protection would remain, but baseline market protection would fall from two years to one under the EU’s near-final pharmaceutical overhaul. That change puts development economics alongside faster regulatory review as a board-level concern. Companies planning European programs

By the end of this decade, the medical imaging AI sector is expected to balloon to a valuation of $17.19 billion as digital diagnostics become a standard pillar of care. This monumental shift highlights how the medical field is rapidly outgrowing traditional manual interpretation, favoring instead